psi national dialogue on waste pharmaceuticals product stewardship forum june 2, 2009
TRANSCRIPT
PSI National Dialogue on
WastePharmaceuticals
Product Stewardship Forum
June 2, 2009
© Product Stewardship Institute, Inc.Spring 2009
Goal of the Pharmaceuticals Dialogue• Reduce the amount of pharmaceuticals that become waste.
• Develop and implement a nationally-coordinated system for the safe, practical, legal, and environmentally protective management of waste pharmaceuticals.
Focus: waste pharmaceuticals generated from households, or as household waste (including pets).
2
© Product Stewardship Institute, Inc.Spring 2009
Process Research/stakeholder interviews
2 meetings
4 workgroups Research
Source Reduction
Collection/disposal
Regulations
3
4
© Product Stewardship Institute, Inc.Spring 2009 5
Federal Government U.S. Department of Transportation
U.S. Environmental Protection Agency
U.S. Food and Drug Administration
U.S. Postal Service
Office of National Drug Control Policy (observers)
Offices of Congressmen Inslee and Moran
© Product Stewardship Institute, Inc.Spring 2009
Pharmaceutical Companies/Waste Industry
6
AstraZeneca
BD Medical
GlaxoSmithKline
Generic Pharmaceutical Association
Hoffman-La Roche
Johnson & Johnson
King Pharmaceuticals ( and Alpharma)
Purdue Pharmaceuticals
Schering-Plough
Capital Returns, Inc.
Clean Harbors, LLC
Enserv West
EXP Pharmaceuticals
Heritage Environmental Services
Integrated Waste Control, LLC
PharmWaste Technologies
Sharps Compliance, Inc.
Stericycle
Veolia Environmental Services
Waste Management
© Product Stewardship Institute, Inc.Spring 2009
Pharmacies/Pharmacists/Healthcare Groups
7
American Pharmacists Association
Avalere Health, LLC
California Retailers Association
Healthcare Without Harm
Healthcare Distribution Management Association
Kaiser Permanente
Maryland Hospitals for a Healthy Environment
National Association of Chain Drug Stores
National Community Pharmacists Association
National Association of Consultant Pharmacists
National Association of Medical Device Reprocessors
PharmEcology Associates
Teleosis Institute
© Product Stewardship Institute, Inc.Spring 2009
Water, Environment & Public Health
8
Alliance for the Great Lakes
American Water Works Association
Association of State Drinking Water Administrators
Association of State and Interstate Water Pollution Control Administrators
California Product Stewardship Council & Northwest Product Stewardship Council
Clean Water Action
Earth 911
Environmental Working Group
IL/IN Sea Grant
Natural Resources Defense Council
National Association of Clean Water Agencies
National Association of Drug Diversion Investigators
National Safety Council
New England Interstate Water Pollution Control Commission
Oregon Poison Control
Save the Bay
Washington Citizens for Resource Conservation
Women’s Health and Environment Network
What is the size of the problem?
What is the size of the problem?
The Problem
Disposal Options for Waste Pharmaceuticals
Household Trash Disposal
Household Trash Disposal
Flushing (13 Substances)
Take-backs
Source ReductionSource Reduction
Reduce Regulatory Barriers to Cut Cost, Ensure Safety,
Enhance Environment
Reduce Regulatory Barriers to Cut Cost, Ensure Safety,
Enhance Environment
Preferred Disposal Facilities
Preferred Disposal Facilities
Clear & Consistent Message
10
© Product Stewardship Institute, Inc.Spring 2009
Facilitating Cost-effective Take-back
11
• Comments to DEA• Comments to EPA
– UWR Change
• Input on Inslee/Moran bill• Upcoming call to discuss next steps
© Product Stewardship Institute, Inc.Spring 2009
Trash vs. Take-back• Some ready to move, some want more information
• Complex questions to answer:– What are people most likely to do?– Excretion v. disposal?– Impact on poisonings/diversion?
• Ultimate disposal options– Preferred disposal for envt/safety– Capacity– Upcoming calls
12
© Product Stewardship Institute, Inc.Spring 2009
Source Reduction• Convene a summit to bring the “front end” and the “back
end” of the problem together.
• Potential strategies:- use samples differently- dispense smaller quantities- improve patient compliance- more accurate dosing- choose drugs according to ecotoxicity
13
© Product Stewardship Institute, Inc.Spring 2009
PSI Letters of Support Maine Oregon Washington
14
© Product Stewardship Institute, Inc.Spring 2009
For more information
PSI webpage:http://www.productstewardship.us/pharmaceuticals
Sierra Fletcher, Associate-Policy and Programs(617) [email protected]
16